Risks of anti-<i>Helicobacter</i> therapy and long-term therapy with antisecretory drugs. [PDF]
Kotelevets SM.
europepmc +1 more source
Endoscopic Examination and Long-Term Use of Proton Pump Inhibitors for Gastroesophageal Reflux Disease Treatment in Japan. [PDF]
Takami A +4 more
europepmc +1 more source
<i>Peperomia campylotropa</i> A.W. Hill: Ethnobotanical, Phytochemical, and Metabolomic Profile Related to Its Gastroprotective Activity. [PDF]
Márquez-Flores YK +4 more
europepmc +1 more source
The Use of Proton Pump Inhibitors Among Adults in Norway-A Nationwide Drug Utilization Study. [PDF]
Fossmark R +4 more
europepmc +1 more source
Case Report: Treatment of refractory lung disease in systemic juvenile idiopathic arthritis with cyclophosphamide and rituximab combination therapy. [PDF]
Freeman WJ, Rife EC, Cron RQ.
europepmc +1 more source
Gastric perforation at the extremes of age: a comparative case report of NSAID-associated high-grade dysplasia versus methamphetamine-induced ischemic perforation. [PDF]
Paul A +3 more
europepmc +1 more source
S-Methylmethionine (Vitamin U): A Critical Narrative Review of Pharmacological Mechanisms, Evidence Levels, and Translational Barriers. [PDF]
Ananian AA +11 more
europepmc +1 more source
Engineering a protease-stable, oral single-domain antibody to inhibit IL-23 signaling. [PDF]
Ota N +24 more
europepmc +1 more source
Antiplatelet-Proton Pump Inhibitor Interactions and Arterial Thrombotic Events: A Pharmacovigilance Assessment using Disproportionality and Interaction Analysis. [PDF]
Sridharan K.
europepmc +1 more source
An Evaluation of Oral Anticoagulant Safety Indicators by England's Community Pharmacies. [PDF]
Parekh S, Xu L, Livingstone C.
europepmc +1 more source

